Lilly and Incyte Provide Update on Baricitinib
Go back to Lilly and Incyte Provide Update on Baricitinib| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 120.77 -0.3 (0.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $121.07 | 52 Week High | $118.49 | |||
| Open | $119.54 | 52 Week Low | $55.00 | |||
| Day High | $121.57 | P/E | N/A | |||
| Day Low | $118.88 | EPS | $-0.56 | |||
| Volume | 1,055,260 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1220.28 +5.26 (0.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1215.02 | 52 Week High | $88.16 | |||
| Open | $1201.73 | 52 Week Low | $67.88 | |||
| Day High | $1226.50 | P/E | 282.47 | |||
| Day Low | $1191.08 | EPS | $4.32 | |||
| Volume | 1,938,190 | |||||
